By Lillian Parr
Join the Council on Strategic Risks as we host COVID-19 Response Technologies & Their Future Role in Pathogen Early Warning on Wednesday, February 23 from 12:00–12:45 EST. RSVP here.
This discussion will be hosted by Christine Parthemore, CEO of the Council on Strategic Risks. We are thrilled to host panelists from two companies that have led the way in developing innovative COVID-19 response technologies.
Dr. Mariana Matus, CEO and Cofounder of Biobot Analytics, will share how Biobot has pioneered wastewater testing to detect COVID-19 outbreaks and variant trends — and how this technology will be critical in early warning for future biological threats.
Matthew McKnight, Chief Commercial Officer at Ginkgo Bioworks, and leader of Concentric by Ginkgo, will discuss Concentric’s K-12 COVID-19 testing program and the future of this effort.
Our panel discussion will be followed by an audience Q&A. This event will be recorded and open to the public, including members of the press.